Stock Analysis
Analabs Resources Berhad (KLSE:ANALABS) Third Quarter 2024 Results
Key Financial Results
- Revenue: RM39.9m (up 13% from 3Q 2023).
- Net income: RM2.78m (up 117% from 3Q 2023).
- Profit margin: 7.0% (up from 3.6% in 3Q 2023). The increase in margin was driven by higher revenue.
- EPS: RM0.026 (up from RM0.012 in 3Q 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Analabs Resources Berhad's share price is broadly unchanged from a week ago.
Risk Analysis
It is worth noting though that we have found 2 warning signs for Analabs Resources Berhad (1 is a bit unpleasant!) that you need to take into consideration.
Valuation is complex, but we're helping make it simple.
Find out whether Analabs Resources Berhad is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.
View the Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About KLSE:ANALABS
Analabs Resources Berhad
Analabs Resources Berhad, an investment holding company, manufactures, formulates, and sells resins, chemicals, and building materials in Malaysia, rest of Asia, Australia, and internationally.
Solid track record and good value.
